NCT00833105

Brief Summary

The purpose of this study is to determine if tetraplegic individuals with incomplete spinal cord injury (SCI) who remain unable to move their arms normally 1 year after their SCIs are able to sense and move the affected arm(s) better after 10-13 weeks of treatment with a new robotic therapy device. The hypothesis is that using the AMES device on the arm(s) of chronic tetraplegic subjects with incomplete SCI will result in improved strength, sensation, and functional movement in treated limb(s).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2009

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

January 29, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 30, 2009

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
7.3 years until next milestone

Results Posted

Study results publicly available

April 8, 2019

Completed
Last Updated

May 1, 2019

Status Verified

April 1, 2019

Enrollment Period

2.8 years

First QC Date

January 29, 2009

Results QC Date

January 27, 2015

Last Update Submit

April 16, 2019

Conditions

Keywords

Incomplete Spinal Cord InjuryRehabilitationUpper ExtremityAMES deviceIncomplete SCIQuadriplegia

Outcome Measures

Primary Outcomes (1)

  • Grasp Release Test

    The task involves picking up, transporting, and placing six objects (i.e., peg, paperweight, fork, block, can, and videotape). Movement of each of the 6 objects is scored based on the number of times the participant can move the object in 30 seconds, with a minimum score of zero if no objects are successfully moved. A cumulative score is based on the sum of all completed movements for all 6 objects.

    Prior to training (baseline), after 25 training sessions (about 8 weeks), 3 months post-training

Secondary Outcomes (12)

  • ASIA Motor Key Muscles

    Prior to training (baseline), after 25 training sessions (about 8 weeks), 3 months post-training

  • ASIA (ISNCSCI) Sensory/Key Sensory Points/ Light-Touch

    Prior to training (baseline), after 25 training sessions (about 8 weeks), 3 months post-training

  • ASIA (ISNCSCI) Sensory/Key Sensory Points/Pin-Prick

    Prior to training (baseline), after 25 training sessions (about 8 weeks), 3 months post-training

  • Van Lieshout Hand Function Test for Tetraplegia- Short Version

    Prior to training (baseline), after 25 training sessions (about 8 weeks), 3 months post-training

  • Modified Ashworth Scale

    Prior to training (baseline), after 25 training sessions (about 8 weeks), 3 months post-training

  • +7 more secondary outcomes

Study Arms (1)

AMES treatment

EXPERIMENTAL

The subject will receive 25 treatment sessions, conducted 2-3 times per week on the AMES device. Each session will consist of testing followed by 30 minutes of wrist and finger rehabilitation using the AMES device.

Device: AMES treatment

Interventions

The AMES device rotates the fingers-thumb or the wrist in the flexion-extension directions over a range of 30 degrees while vibrators stimulate the tendons attached to muscles that are lengthened by the thumb-finger or hand movement. A treatment consists of 20 minutes of fingers-thumb movement, followed by 10 minutes of wrist movement. The subject's task is to assist the motion of the device.

AMES treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Traumatic SCI with tetraplegia.
  • Male or female.
  • yrs old.
  • At least 1 yr post-SCI.
  • Tolerate sitting upright at for at least one hour.
  • Able to perceive direction of passive joint(s) motion of the upper extremity(ies) to be treated 70% or more of the times tested.
  • Motor grade \>1 in the wrist extensors, finger flexors and finger abductors (the 3 muscles related to hand movements in the ASIA scale) in the upper extremity tested.
  • Cognitively and behaviorally capable of complying with the regimen.

You may not qualify if:

  • Fracture of the treated limb resulting in loss of range of motion
  • Concomitant TBI or stroke (Patients who sustained mild head injury during the trauma with no evidence of structural abnormalities on brain images will qualify for the study)
  • DVT of the treated extremity
  • Peripheral nerve injury of the treated extremity
  • Osteo- or rheumatoid-arthritis limiting range of motion
  • Contractures equal to or greater than 50% of the normal ROM
  • Skin condition not tolerant of device
  • Progressive neurodegenerative disorder
  • Botox treatment of the treated extremity in the prior 5 month
  • Chronic ITB therapy
  • Uncontrolled seizure disorder
  • Uncontrolled high blood pressure/angina
  • Pain in affected limb or exercise intolerance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shepherd Center

Atlanta, Georgia, 30309, United States

Location

Oregon Health and Science University

Portland, Oregon, 97006, United States

Location

Related Publications (1)

  • Cordo P, Lutsep H, Cordo L, Wright WG, Cacciatore T, Skoss R. Assisted movement with enhanced sensation (AMES): coupling motor and sensory to remediate motor deficits in chronic stroke patients. Neurorehabil Neural Repair. 2009 Jan;23(1):67-77. doi: 10.1177/1545968308317437. Epub 2008 Jul 21.

MeSH Terms

Conditions

Spinal Cord InjuriesQuadriplegiaParesisParalysis

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

1. Not a controlled study. 2. Zone of partial preservation not fully characterized. 3. Changes in somatosensation were not quantified. 4. Five participants were trained for both ULs, so training of first UL may have affected second UL.

Results Point of Contact

Title
Dr. Paul Cordo
Organization
Oregon Health & Science University

Study Officials

  • Paul J. Cordo, Ph.D

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR
  • Deborah Backus, PhD, PT

    Shepherd Center, Atlanta GA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Principal Investigator

Study Record Dates

First Submitted

January 29, 2009

First Posted

January 30, 2009

Study Start

January 1, 2009

Primary Completion

November 1, 2011

Study Completion

January 1, 2012

Last Updated

May 1, 2019

Results First Posted

April 8, 2019

Record last verified: 2019-04

Locations